146 related articles for article (PubMed ID: 18414472)
1. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.
Lim SL; Smith P; Syed N; Coens C; Wong H; van der Burg M; Szlosarek P; Crook T; Green JA
Br J Cancer; 2008 Apr; 98(8):1452-6. PubMed ID: 18414472
[TBL] [Abstract][Full Text] [Related]
2. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
Wang Z; Li M; Lu S; Zhang Y; Wang H
Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Taniguchi T; Tischkowitz M; Ameziane N; Hodgson SV; Mathew CG; Joenje H; Mok SC; D'Andrea AD
Nat Med; 2003 May; 9(5):568-74. PubMed ID: 12692539
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.
Tokunaga E; Okada S; Kitao H; Shiotani S; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
Breast Cancer; 2011 Apr; 18(2):120-3. PubMed ID: 19813073
[TBL] [Abstract][Full Text] [Related]
6. FANCF methylation contributes to chemoselectivity in ovarian cancer.
Olopade OI; Wei M
Cancer Cell; 2003 May; 3(5):417-20. PubMed ID: 12781358
[TBL] [Abstract][Full Text] [Related]
7. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract][Full Text] [Related]
8. RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.
He M; Sun HG; Hao JY; Li YL; Yu JK; Yan YY; Zhao L; Li N; Wang Y; Bai XF; Yu ZJ; Zheng ZH; Mi XY; Wang EH; Wei MJ
Oncol Rep; 2013 May; 29(5):1721-9. PubMed ID: 23440494
[TBL] [Abstract][Full Text] [Related]
9. Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
Swisher EM; Gonzalez RM; Taniguchi T; Garcia RL; Walsh T; Goff BA; Welcsh P
Mol Cancer; 2009 Jul; 8():48. PubMed ID: 19602291
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Wei M; Xu J; Dignam J; Nanda R; Sveen L; Fackenthal J; Grushko TA; Olopade OI
Breast Cancer Res Treat; 2008 Sep; 111(1):113-20. PubMed ID: 17932744
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer.
Bonito NA; Borley J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Brown R
Clin Cancer Res; 2016 Jun; 22(12):3097-3104. PubMed ID: 26763252
[TBL] [Abstract][Full Text] [Related]
12. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
[TBL] [Abstract][Full Text] [Related]
13. Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line.
Parashar G; Parashar NC; Capalash N
Mol Cell Biochem; 2012 Jun; 365(1-2):29-35. PubMed ID: 22297615
[TBL] [Abstract][Full Text] [Related]
14. FANCF hypomethylation is associated with colorectal cancer in Han Chinese.
Yu H; Pan R; Gao T; Wu D; Ying J; Duan S
Turk J Gastroenterol; 2020 Aug; 31(8):558-565. PubMed ID: 32915143
[TBL] [Abstract][Full Text] [Related]
15. Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.
Kessous R; Octeau D; Klein K; Tonin PN; Greenwood CMT; Pelmus M; Laskov I; Kogan L; Salvador S; Lau S; Yasmeen A; Gotlieb WH
Gynecol Oncol; 2018 Mar; 148(3):553-558. PubMed ID: 29395310
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer.
Tian H; Yan L; Xiao-Fei L; Hai-Yan S; Juan C; Shan K
Clin Epigenetics; 2019 Oct; 11(1):153. PubMed ID: 31666131
[TBL] [Abstract][Full Text] [Related]
17. Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients: A Study of the Tumor Bank Ovarian Cancer Consortium.
Sun T; Ruscito I; Dimitrova D; Chekerov R; Kulbe H; Baron U; Blanchard V; Panici PB; Darb-Esfahani S; Sehouli J; Olek S; Braicu EI
Int J Gynecol Cancer; 2017 Oct; 27(8):1658-1665. PubMed ID: 28691938
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer.
Akahira J; Sugihashi Y; Ito K; Niikura H; Okamura K; Yaegashi N
Cancer Sci; 2004 Jan; 95(1):40-3. PubMed ID: 14720325
[TBL] [Abstract][Full Text] [Related]
19. Fancf-deficient mice are prone to develop ovarian tumours.
Bakker ST; van de Vrugt HJ; Visser JA; Delzenne-Goette E; van der Wal A; Berns MA; van de Ven M; Oostra AB; de Vries S; Kramer P; Arwert F; van der Valk M; de Winter JP; te Riele H
J Pathol; 2012 Jan; 226(1):28-39. PubMed ID: 21915857
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 promoter hypermethylation and protein expression in ovarian carcinoma--an Indian study.
Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 May; 35(5):4277-84. PubMed ID: 24385383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]